Oligonucleotide Synthesis Market Synopsis:
Oligonucleotide Synthesis Market Size Was Valued at USD 10.49 Billion in 2023, and is Projected to Reach USD 12.45 Billion by 2032, Growing at a CAGR of 16% From 2024-2032.
The oligonucleotide synthesis market has been witnessing significant growth due to the increasing demand for customized oligonucleotides in molecular biology, diagnostics, and therapeutic applications. Oligonucleotides, short sequences of nucleotides, are used in various research and diagnostic processes, including PCR, sequencing, gene synthesis, and antisense therapy. The growing adoption of oligonucleotide-based therapies, especially in the field of genetic disorders, has further propelled the market. Additionally, the rising prevalence of diseases requiring personalized medicine has fueled demand for oligonucleotide synthesis.
Technological advancements in oligonucleotide synthesis platforms have also been pivotal in shaping market dynamics. Innovations such as improvements in automated synthesizers, faster synthesis processes, and cost-effective solutions have made oligonucleotide synthesis more accessible and efficient. Moreover, the advent of next-generation sequencing (NGS) and RNA interference (RNAi) technologies has opened new avenues for the use of oligonucleotides in research, diagnostics, and drug development. These advancements are expected to continue driving growth in the market in the coming years.
Market Dynamics: The oligonucleotide synthesis market is heavily influenced by the rising prevalence of chronic diseases, including cancer and genetic disorders, where oligonucleotide-based treatments such as antisense oligonucleotides (ASOs) are gaining traction. The demand for precision medicine and tailored therapies is expected to increase, further driving the market. Furthermore, the rapid advancement in genomic technologies and an increase in funding for genomics and biotechnology research are contributing factors.
However, market growth is somewhat hindered by the high costs associated with oligonucleotide synthesis and the complexity involved in large-scale production. Additionally, regulatory challenges related to the approval of oligonucleotide-based drugs could slow the pace of adoption in certain regions. Despite these challenges, the growing focus on personalized medicine and the continuous development of new applications for oligonucleotides are expected to positively influence market growth in the coming years.
Oligonucleotide Synthesis Market Trend Analysis:
Increasing Demand for Personalized Medicine
-
The demand for personalized medicine is rapidly growing, and oligonucleotides are playing a critical role in this revolution. Personalized medicine focuses on tailoring treatments based on individual genetic profiles, and oligonucleotides are crucial in developing targeted therapies for genetic disorders, cancer, and other chronic diseases. These synthetic molecules are being used in gene silencing, gene editing, and the production of specific therapeutic agents that can directly target disease-causing genes. As personalized treatment plans become more common, the need for oligonucleotide synthesis to support these innovations continues to increase.
- Moreover, the advancement of gene-editing technologies, particularly CRISPR, is further pushing the demand for precise oligonucleotides in creating custom sequences for therapeutic applications. The ability to target specific genes for modification or correction has made oligonucleotides an essential tool in developing new treatments, particularly in oncology and rare genetic diseases. This expanding use in precision therapies is likely to drive continued growth in the oligonucleotide synthesis market, as the healthcare industry increasingly looks for solutions tailored to individual patients’ needs.
Technological Advancements in Oligonucleotide Synthesis Platforms
-
Technological advancements in oligonucleotide synthesis platforms have significantly contributed to market expansion. Automation, miniaturization, and advancements in synthesizer technology have improved the speed, accuracy, and cost-effectiveness of oligonucleotide production. Automated synthesizers can now produce large volumes of oligonucleotides with minimal human intervention, allowing for more efficient large-scale synthesis and a reduction in production costs. These innovations have made it easier for research and diagnostic labs, as well as biotech companies, to access high-quality oligonucleotides for their experiments and treatments.
- Next-generation synthesis platforms are now capable of producing longer and more complex sequences at a higher throughput. These improvements have made oligonucleotide synthesis more viable for new applications such as RNA interference (RNAi) therapies and CRISPR-based gene editing. With these technological advancements, the oligonucleotide synthesis market is becoming more accessible, with a wider range of customers able to utilize oligonucleotide-based solutions for research, diagnostics, and therapeutic development. The trend toward more efficient and advanced technologies is expected to continue shaping the market in the coming years.
Oligonucleotide Synthesis Market Segment Analysis:
Oligonucleotide Synthesis Market Segmented on the basis of By Product, Type, Application and End User.
By Product, Oligonucleotide segment is expected to dominate the market during the forecast period
-
Based on the product type, oligonucleotide synthesis market is divided into; oligonucleotides, reagents, and equipment, which are all important for synthesizing molecules. However, among those oligonucleotides themselves are the largest segment due to their utility in diagnosis, treatment, and research. One of the reasons for the development of oligonucleotide synthesis is the growing interest in the synthesis individualized oligonucleotide sequences used in personalized medicine. Nucleotides, solvents, protective groups which are widely used for the synthesis of oligonucleotides affect the market growth due to an increase in the demand for efficient and high-quality synthesis processes. Reagents, for example synthesizers and purification systems, are also experiencing shift toward more efficiency and automation enhanced by high throughput technologies in the laboratory setting. Collectively, these product categories highlight the rapidly growing oligonucleotide synthesis market, with its focus on innovative products and customized solutions for clients in the life science sector.
By Application, Therapeutic Applications segment expected to held the largest share
-
The market of oligonucleotide synthesis would see a future growth in numerous areas as a therapeutic tool, diagnostic tool, tool for carrying out research, and others. Oligonucleotides have a significant role in the therapeutic application to formulate new treatments including genes, RNA interference and the antisense oligonucleotides useful in gene therapy, RNA interference and cancers in genetic disorder therapy. In diagnostics, synthesized oligonucleotides have found their application in creating better and efficient molecular diagnosis, for instance, PCR tests and next-generation sequencing, which can be used for early diagnosis of diseases and also tracking health states. Moreover, in research context, oligonucleotides are critical reagents for gene engineering, gene function analysis, studying biological processes leading to the progress of molecular biology and genetics knowledge. With progressive growth of these multiple applications, there is continued demand growth and applicational advances across the oligonucleotide synthesis market in the preceding industries.
Oligonucleotide Synthesis Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast period
-
The oligonucleotide synthesis market is expected to show North America as the largest market during the given forecast period due to several drivers. The area is highly developed in terms of biotechnology and contains a number of pharmaceutical companies so the R & D investments push the demand for synthesized oligonucleotides in diagnostics, treatment as well as in genomics. Further, the existence of major industry players and key academic research organizations in the United States provides the necessary encouraging environment to enhance oligonucleotide synthesis technologies. The trends towards personalization of medicine, more frequent detection of genetic and rare diseases simply enhance the need for custom oligonucleotides, thus keeping North America a market leader in a field which is experiencing very spectacular growth.
Active Key Players in the Oligonucleotide Synthesis Market:
- Agilent Technologies, Inc. (U.S.)
- Ajinomoto Co., Inc. (Japan)
- Atdbio Ltd. (U.K)
- Bio-Synthesis Inc. (U.S.)
- Danaher (U.S.)
- Eurofins Genomics (India)
- Genedesign, Inc. (Tokyo)
- General Electric (U.S.)
- Genscript (U.S.)
- Kaneka Eurogentec S.A.(Belgium)
- LGC Limited (U.K)
- Merck KgaA (Germany)
- Other Active Players
|
Global Oligonucleotide Synthesis Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 10.49 Billion |
|
Forecast Period 2024-32 CAGR: |
16% |
Market Size in 2032: |
USD 12.45 Billion |
|
Segments Covered: |
By Product |
|
|
|
By Type |
|
||
|
Application |
|
||
|
End User |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Oligonucleotide Synthesis Market by Product
4.1 Oligonucleotide Synthesis Market Snapshot and Growth Engine
4.2 Oligonucleotide Synthesis Market Overview
4.3 Oligonucleotide
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Oligonucleotide: Geographic Segmentation Analysis
4.4 Reagents
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Reagents: Geographic Segmentation Analysis
4.5 and Equipment
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 and Equipment: Geographic Segmentation Analysis
Chapter 5: Oligonucleotide Synthesis Market by Type
5.1 Oligonucleotide Synthesis Market Snapshot and Growth Engine
5.2 Oligonucleotide Synthesis Market Overview
5.3 Custom Oligos and Predesigned Oligos
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Custom Oligos and Predesigned Oligos: Geographic Segmentation Analysis
Chapter 6: Oligonucleotide Synthesis Market by Application
6.1 Oligonucleotide Synthesis Market Snapshot and Growth Engine
6.2 Oligonucleotide Synthesis Market Overview
6.3 Therapeutic Applications
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Therapeutic Applications: Geographic Segmentation Analysis
6.4 Diagnostics
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Diagnostics: Geographic Segmentation Analysis
6.5 Research
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Research: Geographic Segmentation Analysis
6.6 and Others
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 and Others: Geographic Segmentation Analysis
Chapter 7: Oligonucleotide Synthesis Market by End User
7.1 Oligonucleotide Synthesis Market Snapshot and Growth Engine
7.2 Oligonucleotide Synthesis Market Overview
7.3 Academic Research Institutes
7.3.1 Introduction and Market Overview
7.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.3.3 Key Market Trends, Growth Factors and Opportunities
7.3.4 Academic Research Institutes: Geographic Segmentation Analysis
7.4 Pharmaceutical and Biotechnology Companies
7.4.1 Introduction and Market Overview
7.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.4.3 Key Market Trends, Growth Factors and Opportunities
7.4.4 Pharmaceutical and Biotechnology Companies: Geographic Segmentation Analysis
7.5 Diagnostic Laboratories
7.5.1 Introduction and Market Overview
7.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.5.3 Key Market Trends, Growth Factors and Opportunities
7.5.4 Diagnostic Laboratories: Geographic Segmentation Analysis
7.6 and Others
7.6.1 Introduction and Market Overview
7.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.6.3 Key Market Trends, Growth Factors and Opportunities
7.6.4 and Others: Geographic Segmentation Analysis
Chapter 8: Company Profiles and Competitive Analysis
8.1 Competitive Landscape
8.1.1 Competitive Benchmarking
8.1.2 Oligonucleotide Synthesis Market Share by Manufacturer (2023)
8.1.3 Industry BCG Matrix
8.1.4 Heat Map Analysis
8.1.5 Mergers and Acquisitions
8.2 AGILENT TECHNOLOGIES INC. (U.S.)
8.2.1 Company Overview
8.2.2 Key Executives
8.2.3 Company Snapshot
8.2.4 Role of the Company in the Market
8.2.5 Sustainability and Social Responsibility
8.2.6 Operating Business Segments
8.2.7 Product Portfolio
8.2.8 Business Performance
8.2.9 Key Strategic Moves and Recent Developments
8.2.10 SWOT Analysis
8.3 ATDBIO LTD. (U.K.)
8.4 LGC LIMITED (U.K.)
8.5 BIO-SYNTHESIS INC. (U.S.)
8.6 EUROFINS GENOMICS (INDIA)
8.7 KANEKA EUROGENTEC S.A. (BELGIUM)
8.8 GENERAL ELECTRIC (U.S.)
8.9 GENSCRIPT (U.S.)
8.10 AJINOMOTO CO. INC. (JAPAN)
8.11 GENEDESIGN INC. (TOKYO)
8.12 DANAHER (U.S.)
8.13 MERCK KGAA (GERMANY)
8.14
8.15 OTHER ACTIVE PLAYERS
Chapter 9: Global Oligonucleotide Synthesis Market By Region
9.1 Overview
9.2. North America Oligonucleotide Synthesis Market
9.2.1 Key Market Trends, Growth Factors and Opportunities
9.2.2 Top Key Companies
9.2.3 Historic and Forecasted Market Size by Segments
9.2.4 Historic and Forecasted Market Size By Product
9.2.4.1 Oligonucleotide
9.2.4.2 Reagents
9.2.4.3 and Equipment
9.2.5 Historic and Forecasted Market Size By Type
9.2.5.1 Custom Oligos and Predesigned Oligos
9.2.6 Historic and Forecasted Market Size By Application
9.2.6.1 Therapeutic Applications
9.2.6.2 Diagnostics
9.2.6.3 Research
9.2.6.4 and Others
9.2.7 Historic and Forecasted Market Size By End User
9.2.7.1 Academic Research Institutes
9.2.7.2 Pharmaceutical and Biotechnology Companies
9.2.7.3 Diagnostic Laboratories
9.2.7.4 and Others
9.2.8 Historic and Forecast Market Size by Country
9.2.8.1 US
9.2.8.2 Canada
9.2.8.3 Mexico
9.3. Eastern Europe Oligonucleotide Synthesis Market
9.3.1 Key Market Trends, Growth Factors and Opportunities
9.3.2 Top Key Companies
9.3.3 Historic and Forecasted Market Size by Segments
9.3.4 Historic and Forecasted Market Size By Product
9.3.4.1 Oligonucleotide
9.3.4.2 Reagents
9.3.4.3 and Equipment
9.3.5 Historic and Forecasted Market Size By Type
9.3.5.1 Custom Oligos and Predesigned Oligos
9.3.6 Historic and Forecasted Market Size By Application
9.3.6.1 Therapeutic Applications
9.3.6.2 Diagnostics
9.3.6.3 Research
9.3.6.4 and Others
9.3.7 Historic and Forecasted Market Size By End User
9.3.7.1 Academic Research Institutes
9.3.7.2 Pharmaceutical and Biotechnology Companies
9.3.7.3 Diagnostic Laboratories
9.3.7.4 and Others
9.3.8 Historic and Forecast Market Size by Country
9.3.8.1 Russia
9.3.8.2 Bulgaria
9.3.8.3 The Czech Republic
9.3.8.4 Hungary
9.3.8.5 Poland
9.3.8.6 Romania
9.3.8.7 Rest of Eastern Europe
9.4. Western Europe Oligonucleotide Synthesis Market
9.4.1 Key Market Trends, Growth Factors and Opportunities
9.4.2 Top Key Companies
9.4.3 Historic and Forecasted Market Size by Segments
9.4.4 Historic and Forecasted Market Size By Product
9.4.4.1 Oligonucleotide
9.4.4.2 Reagents
9.4.4.3 and Equipment
9.4.5 Historic and Forecasted Market Size By Type
9.4.5.1 Custom Oligos and Predesigned Oligos
9.4.6 Historic and Forecasted Market Size By Application
9.4.6.1 Therapeutic Applications
9.4.6.2 Diagnostics
9.4.6.3 Research
9.4.6.4 and Others
9.4.7 Historic and Forecasted Market Size By End User
9.4.7.1 Academic Research Institutes
9.4.7.2 Pharmaceutical and Biotechnology Companies
9.4.7.3 Diagnostic Laboratories
9.4.7.4 and Others
9.4.8 Historic and Forecast Market Size by Country
9.4.8.1 Germany
9.4.8.2 UK
9.4.8.3 France
9.4.8.4 The Netherlands
9.4.8.5 Italy
9.4.8.6 Spain
9.4.8.7 Rest of Western Europe
9.5. Asia Pacific Oligonucleotide Synthesis Market
9.5.1 Key Market Trends, Growth Factors and Opportunities
9.5.2 Top Key Companies
9.5.3 Historic and Forecasted Market Size by Segments
9.5.4 Historic and Forecasted Market Size By Product
9.5.4.1 Oligonucleotide
9.5.4.2 Reagents
9.5.4.3 and Equipment
9.5.5 Historic and Forecasted Market Size By Type
9.5.5.1 Custom Oligos and Predesigned Oligos
9.5.6 Historic and Forecasted Market Size By Application
9.5.6.1 Therapeutic Applications
9.5.6.2 Diagnostics
9.5.6.3 Research
9.5.6.4 and Others
9.5.7 Historic and Forecasted Market Size By End User
9.5.7.1 Academic Research Institutes
9.5.7.2 Pharmaceutical and Biotechnology Companies
9.5.7.3 Diagnostic Laboratories
9.5.7.4 and Others
9.5.8 Historic and Forecast Market Size by Country
9.5.8.1 China
9.5.8.2 India
9.5.8.3 Japan
9.5.8.4 South Korea
9.5.8.5 Malaysia
9.5.8.6 Thailand
9.5.8.7 Vietnam
9.5.8.8 The Philippines
9.5.8.9 Australia
9.5.8.10 New Zealand
9.5.8.11 Rest of APAC
9.6. Middle East & Africa Oligonucleotide Synthesis Market
9.6.1 Key Market Trends, Growth Factors and Opportunities
9.6.2 Top Key Companies
9.6.3 Historic and Forecasted Market Size by Segments
9.6.4 Historic and Forecasted Market Size By Product
9.6.4.1 Oligonucleotide
9.6.4.2 Reagents
9.6.4.3 and Equipment
9.6.5 Historic and Forecasted Market Size By Type
9.6.5.1 Custom Oligos and Predesigned Oligos
9.6.6 Historic and Forecasted Market Size By Application
9.6.6.1 Therapeutic Applications
9.6.6.2 Diagnostics
9.6.6.3 Research
9.6.6.4 and Others
9.6.7 Historic and Forecasted Market Size By End User
9.6.7.1 Academic Research Institutes
9.6.7.2 Pharmaceutical and Biotechnology Companies
9.6.7.3 Diagnostic Laboratories
9.6.7.4 and Others
9.6.8 Historic and Forecast Market Size by Country
9.6.8.1 Turkiye
9.6.8.2 Bahrain
9.6.8.3 Kuwait
9.6.8.4 Saudi Arabia
9.6.8.5 Qatar
9.6.8.6 UAE
9.6.8.7 Israel
9.6.8.8 South Africa
9.7. South America Oligonucleotide Synthesis Market
9.7.1 Key Market Trends, Growth Factors and Opportunities
9.7.2 Top Key Companies
9.7.3 Historic and Forecasted Market Size by Segments
9.7.4 Historic and Forecasted Market Size By Product
9.7.4.1 Oligonucleotide
9.7.4.2 Reagents
9.7.4.3 and Equipment
9.7.5 Historic and Forecasted Market Size By Type
9.7.5.1 Custom Oligos and Predesigned Oligos
9.7.6 Historic and Forecasted Market Size By Application
9.7.6.1 Therapeutic Applications
9.7.6.2 Diagnostics
9.7.6.3 Research
9.7.6.4 and Others
9.7.7 Historic and Forecasted Market Size By End User
9.7.7.1 Academic Research Institutes
9.7.7.2 Pharmaceutical and Biotechnology Companies
9.7.7.3 Diagnostic Laboratories
9.7.7.4 and Others
9.7.8 Historic and Forecast Market Size by Country
9.7.8.1 Brazil
9.7.8.2 Argentina
9.7.8.3 Rest of SA
Chapter 10 Analyst Viewpoint and Conclusion
10.1 Recommendations and Concluding Analysis
10.2 Potential Market Strategies
Chapter 11 Research Methodology
11.1 Research Process
11.2 Primary Research
11.3 Secondary Research
|
Global Oligonucleotide Synthesis Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 10.49 Billion |
|
Forecast Period 2024-32 CAGR: |
16% |
Market Size in 2032: |
USD 12.45 Billion |
|
Segments Covered: |
By Product |
|
|
|
By Type |
|
||
|
Application |
|
||
|
End User |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
